Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bioventus Inc

BVS
Current price
4.17 USD +0.26 USD (+6.65%)
Last closed 4 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 248 085 248 USD
Yield for 12 month +95.77 %
Week
Month
Year
BVS
21.11.2021 - 28.11.2021

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for precise bone sculpting, removing tumors, and tissue debridement. The company's restorative therapies include a bone healing system; skin allografts; and products that are used to support healing of wounds, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina. Address: 4721 Emperor Boulevard, Durham, NC, United States, 27703

Analytics

WallStreet Target Price

4.83 USD

P/E ratio

Dividend Yield

Current Year

+64 774 000 USD

Last Year

+430 898 000 USD

Current Quarter

+120 794 000 USD

Last Quarter

+137 069 000 USD

Current Year

+45 808 000 USD

Last Year

+302 706 000 USD

Current Quarter

+78 850 000 USD

Last Quarter

+89 123 000 USD

Key Figures BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 47 994 000 USD
Operating Margin TTM 3.06 %
PE Ratio
Return On Assets TTM -1.43 %
PEG Ratio 2.1421
Return On Equity TTM -67.29 %
Wall Street Target Price 4.83 USD
Revenue TTM 502 756 000 USD
Book Value 2.82 USD
Revenue Per Share TTM 8.06 USD
Dividend Share
Quarterly Revenue Growth YOY -6.1 %
Dividend Yield
Gross Profit TTM 302 706 000 USD
Earnings Share -2.56 USD
Diluted Eps TTM -2.56 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -36.21 %

Dividend Analytics BVS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 12.285
Enterprise Value Revenue 1.0642
Price Sales TTM 0.3129
Enterprise Value EBITDA -3.6275
Price Book MRQ 0.5841

Financials BVS

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BVS

For 52 weeks

0.8 USD 5.09 USD
50 Day MA 3.33 USD
Shares Short Prior Month 1 471 294
200 Day MA 2.66 USD
Short Ratio 13.76
Shares Short 1 483 278
Short Percent 3.82 %